DSIJ Mindshare

Wockhardt receives approval for cancer drug Decibatine inj

Advait Dharmadhikari 0 1048 Article rating: 5.0

Pharma major Wockhardt has received approval from the United States Food & Drug Administration (USFDA) for an ANDA for 50 mg injection of Decibatine, which is used in the treatment of some forms of cancer. Decibatine injection is a generic version of Dacogen, marketed in the USA and other countries by Otsuka.

RSS
First65286529653065316533653565366537Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR